Merck & Co. Under Pressure Following Patent Ruling
December 09, 2014 at 09:30 AM EST
Merck & Co., Inc. (NYSE: MRK) shares traded lower in the pre-market amid news that its deal to acquire Cubist Pharmaceuticals Inc ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.